The anti-inflammatory effect of fish oil enriched with EPA on cancer patients

The anti-inflammatory effect of fish oil enriched with EPA on cancer patients - The effect of fish oil on cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033309

Enrollment

Registered

2018-07-07

Start date

2018-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients

Interventions

Subjects ingest fish oil (EPA 498mg) and a high high-calorie jelly (energy 100kcal, protein 5g) for 8 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Carcinoma patients Outpatients CRP over 0.30 mg/dl Aged 20 or older Oral Ingestible patients Patients who are expected to receive regular ambulatory treatment over 6 months

Exclusion criteria

Exclusion criteria: Food allergies to fish, milk, soybean or gelatin Taking supplement containing fish oil or EPA and DHA drugs Use of steroidal anti-inflammatory drugs Participation in another clinical study Patients who have difficulties to complete the trial Patients who are assessed by the principal investigator to be unsuitable to participate in the study

Design outcomes

Primary

Measure	Time frame
CRP, IL-6, Albumin, Prealbumin	—

Countries

Japan

Contacts

Public ContactKoji Tanaka

Iga City General Hospital Surgery

qoujitanaka@yahoo.co.jp0595-24-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026